Efficacy of Navigable Percutaneous Plasma Disc Decompression Device (L'DISQ) in Patients With Severe Lumbar Disc Herniation
L'DISQ
1 other identifier
observational
30
0 countries
N/A
Brief Summary
This study aims to assess the clinical outcome of percutaneous disc decompression using the L'DISQ in patients with severe lumbar disc herniation (LDH).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Mar 2009
Longer than P75 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 28, 2019
CompletedFirst Submitted
Initial submission to the registry
January 21, 2022
CompletedFirst Posted
Study publicly available on registry
February 9, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
March 31, 2022
CompletedFebruary 9, 2022
February 1, 2022
10 years
January 21, 2022
February 7, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Visual analogue scale (VAS)
VAS (Visual Analogue Scale) is a measuring tool that can quickly and easily measure the level of pain through the patient's expression or attitude.
Change from baseline data, evaluated during the hospitalization prior to the L'DISQ procedure, to 4, 12, 24, and 48 weeks after the procedure.
Secondary Outcomes (5)
Straight Leg Raise Test (SLRT)
Change from baseline data, evaluated during the hospitalization prior to the L'DISQ procedure, to 4, 12, 24, and 48 weeks after the procedure
Roland-Morris Disability Questionnaire (RMDQ)
Change from baseline data, evaluated during the hospitalization prior to the L'DISQ procedure, to 4, 12, 24, and 48 weeks after the procedure
Oswestry Disability Index (ODI)
Change from baseline data, evaluated during the hospitalization prior to the L'DISQ procedure, to 4, 12, 24, and 48 weeks after the procedure
Physical Component Score (PCS) of Short Form-36 version 2 (SF-36v2)
Change from baseline data, evaluated during the hospitalization prior to the L'DISQ procedure, to 4, 12, 24, and 48 weeks after the procedure
Bodily Pain Score (BPS) of Short Form-36 version 2 (SF-36v2)
Change from baseline data, evaluated during the hospitalization prior to the L'DISQ procedure, to 4, 12, 24, and 48 weeks after the procedure
Study Arms (1)
Navigable Percutaneous Plasma Disc Decompression (L'DISQ)
The L'DISQ (U\&I Co., Uijeongbu, Korea) is one of the minimally invasive disc decompression procedures which was introduced in 2011. The L'DISQ uses a navigable tip and flexible handle allowing resection of the posterolateral or posterior median disc tissue without thermal damage.
Interventions
Eligibility Criteria
Patients who have visited the spine center of Korea University Anam Hospital and received the L'DISQ procedure between March 01, 2009 and February 28, 2019
You may qualify if:
- single-level LDH of MSU classification of grade 3 and refusal of spine surgery
- LBP or lower extremity pain symptoms that persisted for 3 months or more
- unresponsiveness to sufficient conservative treatments, including oral analgesics, physical modalities, or spinal injections (such as selective nerve root blocks)
- limited activities of daily living due to pain.
You may not qualify if:
- patients lost during the 1-year follow-up
- evidence of peripheral neuropathy on electromyography, which might cause lower extremity pain
- evidence of vertebral fracture in the X-ray analysis
- history of tumor or myelopathy
- history of spinal surgery
- history of coagulopathy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Target Duration
- 1 Year
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 21, 2022
First Posted
February 9, 2022
Study Start
March 1, 2009
Primary Completion
February 28, 2019
Study Completion
March 31, 2022
Last Updated
February 9, 2022
Record last verified: 2022-02